Results 111 to 120 of about 5,769,168 (249)
Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching Study
Haemophilia, EarlyView.Erin Cockrell, Martin Chandler, Tammuella Chrisentery‐Singleton, Stacy E. Croteau, Nabil Daoud, Michael F. Guerrera, M. Nikki Hirsh, Janna Journeycake, Roshni Kulkarni, Susan U. Lattimore, Catherine McGuinn, Margaret Ragni, Michael Recht, Ulrike M. Reiss, Robert Sidonio Jr., Cliffford M. Takemoto, Michael Tarantino, Annette von Drygalski, Ellis J. Neufeld +18 morewiley +1 more sourceGlycoengineered Recombinant Alpha1‐Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma‐Derived Protein
Biotechnology and Bioengineering, Volume 123, Issue 10, Page 2605-2612, October 2026.ABSTRACT
Alpha‐1‐antitrypsin (A1AT) is a multifunctional, clinically important, high‐value therapeutic glycoprotein that can be used for the treatment of many diseases, such as A1AT deficiency, diabetes, graft‐versus‐host disease, cystic fibrosis, and various viral infections. Currently, the only U.S. food and drug administration‐approved treatment for Frances Rocamora, Chen‐Lin Hsieh, Sanne Schoffelen, Johnny Arnsdorf, Eric A. Toth, Abdul S. Yunus, Thomas E. Cleveland IV, Sara Petersen Bjørn, Mina Ying Min Wu, Noel G. McElvaney, Bjørn Gunnar Rude Voldborg, Thomas R. Fuerst, Nathan E. Lewis +12 morewiley +1 more sourceMetabolic Flux Analysis Reveals Cell Line‐Specific Rewiring in CHO Cells Following TCA Cycle Intermediate Feeding for Bioprocess pH Control
Biotechnology and Bioengineering, Volume 123, Issue 10, Page 2713-2728, October 2026.ABSTRACT
Chinese hamster ovary (CHO) cells are the leading host for recombinant therapeutic protein production in the biopharma industry. In this study, we investigated how feeding acidic forms of tricarboxylic acid (TCA) cycle intermediates—malic acid, succinic acid, and α‐ketoglutaric acid—affects cell culture performance and metabolism in two ...Sarah A. Sacco, Kevin J. Ruiz‐Márquez, Rachel Moen, Irina Trenary, Xiaolin Zhang, Xiaowen Wang, Malik Padellan, Henry Lin, Jamey D. Young +8 morewiley +1 more sourceModel-directed engineering of “difficult-to-express” monoclonal antibody production by Chinese hamster ovary cells
, 2013 This article is not available through ChesterRep.Despite improvements in volumetric titer for monoclonal antibody (MAb) production processes using Chinese hamster ovary (CHO) cells, some “difficult-to-express” (DTE) MAbs inexplicably reach much lower ...Field, Ray, Leon P. Pybus, Smith, Andrew, Stephen J. Wilkinson, West, Nathan R., Nathan R. West, Daramola, Olalekan, James, David C., Ray Field, Dean, Greg, Andrew Smith, Olalekan Daramola, Pybus, Leon P., Wilkinson, Stephen J., Greg Dean, David C. James +15 morecore +1 more sourceProduction of the High Value Pharmaceutical Target, Human Granulocyte‐Colony Stimulating Factor, in Nicotiana benthamiana Is Improved by Co‐Expression of the Transcriptional Regulator of the Unfolded Protein Response, bZIP60
Plant Biotechnology Journal, EarlyView.Nazgul Wagner, Konstantin Musiychuk, Stephen Tottey, Jukka Kervinen, Hong Bi, Stephen J. Streatfield, Rainer Fischer, Vidadi Yusibov +7 morewiley +1 more sourceEsterified cholesterol and triglyceride are present in plasma membranes of Chinese hamster ovary cells
, 1992 This article is free to read on the publishers website\ud
\ud
The chemical composition of highly purified plasma membrane preparations from a series of malignant Chinese hamster ovary (CHO) cell lines were undertaken to ascertain if neutral lipid ...Mackinnon, WB, Mountford, CE, Mountford, Carolyn E., May, George L., May, GL, Mackinnon, Wanda B. +5 morecore +1 more sourceProduction of Functional Trastuzumab in Phaeodactylum tricornutum: Advancing Microalgae as Next‐Generation Sustainable Antibody Biofactories
Plant Biotechnology Journal, EarlyView.Charlotte Toustou, Manon Salvetti, Magalie Bénard, Christelle Fécourt, Sébastien Calbo, Kylian Jouie, France Blanchard, Camille N'Zué, Chloé Placines, Thomas Badou, Nicolas Piton, Patrice Lerouge, Ludovic Galas, Muriel Bardor +13 morewiley +1 more sourceMicrobial Hydrolysates as Amino Acid Source in Cell Culture Media for Cellular Agriculture
Biotechnology and Bioengineering, Volume 123, Issue 10, Page 2520-2535, October 2026.ABSTRACT
The high cost of cultivation media remains one of the barriers to the commercialization of cultivated meat. Current serum‐free media reduce reliance on fetal bovine serum but only achieve modest cost savings. Especially at larger scales (> 20 m3), pharmaceutical‐grade amino acids and recombinant proteins remain major cost drivers.Jelle C. Hoek, Jean‐Marc Daran, Marieke E. Klijn, Marcel A. Vieira‐Lara +3 morewiley +1 more source